Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 22 Leukemia, Myeloid, Acute 21 Breast Neoplasms 19 Neoplasm Metastasis 16 Pancreatic Neoplasms 15 Multiple Myeloma 14 Prostatic Neoplasms 12 Melanoma 12 Lymphoma 11 Colorectal Neoplasms 11 Carcinoma, Renal Cell 11 Carcinoma, Non-Small-Cell Lung 11 Burkitt Lymphoma 10 Triple Negative Breast Neoplasms 9 Urinary Bladder Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 8 Ovarian Neoplasms 8 Myelodysplastic Syndromes 8 Mouth Neoplasms 8 Glioma 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Oropharyngeal Neoplasms 7 Leukemia, Lymphocytic, Chronic, B-Cell 7 Laryngeal Neoplasms 7 Fallopian Tube Neoplasms 7 Carcinoma, Hepatocellular 7 Carcinoma 7 Sarcoma 6 Nasopharyngeal Carcinoma 6 Endometrial Neoplasms 6

Interventions

pembrolizumab 2 enfortumab vedotin 1 Watchful Waiting 1 Specimen Handling 1 Observation 1 Magnetic Resonance Spectroscopy 1 Cystoscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Ureteral Neoplasms × Specimen Handling × 30 days × Clear all

NCT03244384 2026-05-29

AMBASSADOR

National Cancer Institute (NCI)

Phase 3 Active not recruiting

Ureteral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡